Paulo Lizano1, Olivia Lutz1, George Ling1, Adam M Lee1, Seenae Eum1, Jeffrey R Bishop1, Sinead Kelly1, Ofer Pasternak1, Brett Clementz1, Godfrey Pearlson1, John A Sweeney1, Elliot Gershon1, Carol Tamminga1, Matcheri Keshavan1. 1. The Department of Psychiatry, Beth Israel Deaconess Medical Center, Boston (Lizano, Lutz, Ling, Kelly, Keshavan); the Department of Psychiatry, Harvard Medical School, Boston (Lizano, Kelly, Pasternak, Keshavan); the University of Minnesota Academic Health Center, Minneapolis (Lee, Eum, Bishop); the Departments of Psychology and Neuroscience, Bio-Imaging Research Center, University of Georgia, Athens (Clementz); the Olin Neuropsychiatry Research Center/Institute of Living, Hartford Hospital, Hartford, Conn. (Pearlson); the Department of Psychiatry, University of Cincinnati (Sweeney); the Department of Psychiatry, University of Chicago (Gershon); and the Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas (Tamminga).
Abstract
OBJECTIVE: The choroid plexus is an important physiological barrier and produces CSF and neurotrophic, angiogenic, and inflammatory factors involved in brain development. Choroid plexus abnormalities have been implicated in both schizophrenia and bipolar disorder. A previous choroid plexus transcriptomic analysis of schizophrenia identified an upregulation of immune and inflammatory genes that correlated with peripheral inflammatory markers. The purpose of this study was to examine choroid plexus volume in probands across the psychosis spectrum and in their first-degree and axis II cluster A relatives, as well as choroid plexus familiality and choroid plexus covariance with clinical, cognitive, brain, and peripheral marker measures. METHODS: Choroid plexus volume was quantified (using FreeSurfer) in psychosis probands, their first-degree and axis II cluster A relatives, and healthy control subjects, organized by DSM-IV-TR diagnosis. Analyte, structural connectivity, and genotype data were collected from a subset of study subjects. RESULTS: Choroid plexus volume was significantly larger in probands compared with first-degree relatives or healthy control subjects; first-degree relatives had intermediate enlargement compared with healthy control subjects; and total choroid plexus volume was significantly heritable. Larger volume was associated with worse cognition, smaller total gray matter and amygdala volume, larger lateral ventricle volume, and lower structural connectivity in probands. Associations between larger volume and higher levels of interleukin 6 in probands was also observed. CONCLUSIONS: These findings suggest the involvement of the choroid plexus across the psychosis spectrum with a potential pathophysiological mechanism involving the neuroimmune axis, which functions in maintaining brain homeostasis and interacting with the peripheral immune and inflammatory system. The choroid plexus may be an important target in future research.
OBJECTIVE: The choroid plexus is an important physiological barrier and produces CSF and neurotrophic, angiogenic, and inflammatory factors involved in brain development. Choroid plexus abnormalities have been implicated in both schizophrenia and bipolar disorder. A previous choroid plexus transcriptomic analysis of schizophrenia identified an upregulation of immune and inflammatory genes that correlated with peripheral inflammatory markers. The purpose of this study was to examine choroid plexus volume in probands across the psychosis spectrum and in their first-degree and axis II cluster A relatives, as well as choroid plexus familiality and choroid plexus covariance with clinical, cognitive, brain, and peripheral marker measures. METHODS: Choroid plexus volume was quantified (using FreeSurfer) in psychosis probands, their first-degree and axis II cluster A relatives, and healthy control subjects, organized by DSM-IV-TR diagnosis. Analyte, structural connectivity, and genotype data were collected from a subset of study subjects. RESULTS: Choroid plexus volume was significantly larger in probands compared with first-degree relatives or healthy control subjects; first-degree relatives had intermediate enlargement compared with healthy control subjects; and total choroid plexus volume was significantly heritable. Larger volume was associated with worse cognition, smaller total gray matter and amygdala volume, larger lateral ventricle volume, and lower structural connectivity in probands. Associations between larger volume and higher levels of interleukin 6 in probands was also observed. CONCLUSIONS: These findings suggest the involvement of the choroid plexus across the psychosis spectrum with a potential pathophysiological mechanism involving the neuroimmune axis, which functions in maintaining brain homeostasis and interacting with the peripheral immune and inflammatory system. The choroid plexus may be an important target in future research.
Authors: Paulo L Lizano; Matcheri S Keshavan; Neeraj Tandon; Ian T Mathew; Suraj Sarvode Mothi; Debra M Montrose; Jeffrey K Yao Journal: Schizophr Res Date: 2015-12-11 Impact factor: 4.939
Authors: Kelly C S Roballo; Natalia J N Gonçalves; Naira C G Pieri; Aline F Souza; André F C Andrade; Carlos E Ambrósio Journal: Neurosci Lett Date: 2016-05-12 Impact factor: 3.046
Authors: Brisa S Fernandes; Johann Steiner; Marc L Molendijk; Seetal Dodd; Patricia Nardin; Carlos-Alberto Gonçalves; Felice Jacka; Cristiano A Köhler; Chandan Karmakar; André F Carvalho; Michael Berk Journal: Lancet Psychiatry Date: 2016-11-10 Impact factor: 27.083
Authors: M Morrens; C Overloop; V Coppens; E Loots; M Van Den Noortgate; S Vandenameele; M Leboyer; L De Picker Journal: Mol Psychiatry Date: 2022-04-28 Impact factor: 15.992
Authors: Deepthi Bannai; Paulo Lizano; Megan Kasetty; Olivia Lutz; Victor Zeng; Suraj Sarvode; Leo A Kim; Scot Hill; Carol Tamminga; Brett Clementz; Elliot Gershon; Godfrey Pearlson; John B Miller; Matcheri Keshavan Journal: Psychiatry Res Neuroimaging Date: 2020-02-29 Impact factor: 2.376